Analysis
Global-e Online Reports Record Q4 Revenue and Positive 2026 Growth Outlook
Global-e Online Ltd. (NASDAQ: GLBE), the e-commerce localization platform surpassed annual guidance with 28% revenue growth and projects...
ADVERTISEMENT
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
2,196 articles
Analysis
Fiverr Reports 10% Revenue Growth for Fiscal Year 2025
Fiverr International Ltd. (NYSE: FVRR) reported revenue of $430.9 million for the full year 2025, a 10.1% increase...
Analysis
The Andersons Full Year 2025 Net Income Totals $96 Million
The Andersons, Inc. (Nasdaq: ANDE) reported full year 2025 net profit of $95.7 million. The company’s shares moved...
Analysis
Similarweb Projects 10% Revenue Growth for Fiscal 2026
Similarweb Ltd. (NYSE: SMWB) shares moved -2.15% in Wednesday trading following the disclosure of financial results for the...
Analysis
Pitney Bowes Shares Rise Following Full Year 2025 Results
Pitney Bowes Inc. (NYSE: PBI) shares rose 1.89% in Wednesday trading following the release of financial results for...
Analysis
LGI Homes, Inc. Misses Q4 Estimates, Sees Flat Home Closings in 2026
LGI Homes, Inc. (NASDAQ: LGIH) reported fourth-quarter and full-year 2025 financial results on February 17, 2026. Fourth-quarter adjusted...
Analysis
Palo Alto Networks slides as mixed outlook offsets Q2 earnings beat
Shares of Palo Alto Networks (NASDAQ: PANW) fell 5.2% to $167.00 in early Wednesday trading after the cybersecurity...
Analysis
Otter Tail Corporation Misses Q4 Earnings Estimates, Guides Lower for 2026
Otter Tail Corporation (NASDAQ: OTTR) reported fourth-quarter and full-year 2025 financial results on February 16, 2026. Fourth-quarter diluted...
Analysis
DTE Shares Rise After Q4 2025 Net Income Increase
DTE Energy Company (NYSE: DTE) shares closed at $144.69, up 2.5% intraday at the latest U.S. market close...
Analysis
Halozyme Q4 2025 Earnings Surge: Royalty Revenue Soars 52%
Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38%...
Analysis
AtriCure reports surprise Q4 profit on strong worldwide revenue growth
Shares of AtriCure, Inc. (Nasdaq: ATRC) rose 6.4% to $34.12 in Wednesday morning trading after the medical device...
Analysis
Beta Bionics Shares Edge Higher After Q4 Revenue Jumps 57%, Full-Year Sales Top $100 Million
Shares of Beta Bionics, Inc. (Nasdaq: BBNX) were trading modestly higher in late morning U.S. trading on Wednesday,...